Meeting Report
Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung Cancer
Jennifer Jacky,(1) MSN, ARNP, AOCNP®, Kristin DeGroot,(2) PA-C, and Rebecca Denney,(2) PA-C
From (1)Seattle Cancer Care Alliance, Seattle, Washington; (2)University of Washington Medical Center, Seattle, Washington
Presenters’ disclosures of conflicts of interest are found at the end of this article.
J Adv Pract Oncol 2022;13(3):306–310 |
https://doi.org/10.6004/jadpro.2022.13.3.25 |
© 2022 Harborside™
ABSTRACT
During JADPRO Live Virtual 2021, three advanced practitioners—in surgery, radiation oncology, and medical oncology—discussed their collaboration in the management of resectable early-stage non–small cell lung cancer. The presenters discussed the role of screening and early surgical resection, cancer surveillance after resection, adjuvant and neoadjuvant therapies, as well as novel therapies and their associated toxicities.
For access to the full length article, please
sign in.
